Study of Single-dose DS-3201b in Participants With Hepatic Impairment

NCT04276662 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Daiichi Sankyo